蓝帆医疗：第六届董事会第二十七次会议决议公告

Group 1 - The company announced the approval of a proposal to adjust the conversion price of "Bluefan Convertible Bonds" [2] - This decision was made during the 27th meeting of the sixth board of directors [2] - The announcement was made on the evening of August 14 [2] Group 2 - The adjustment of the conversion price may impact the company's financial strategy and investor sentiment [2] - The move reflects the company's ongoing efforts to optimize its capital structure [2] - The announcement is part of the company's broader financial management initiatives [2]